{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T03:40:26Z","timestamp":1682912426429},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1993,2]]},"DOI":"10.1007\/bf00873906","type":"journal-article","created":{"date-parts":[[2004,12,24]],"date-time":"2004-12-24T19:39:55Z","timestamp":1103917195000},"page":"17-27","source":"Crossref","is-referenced-by-count":2,"title":["A phase I clinical and pharmacokinetic study of the oral and the oral\/ intravenous administration of menogaril"],"prefix":"10.1007","volume":"11","author":[{"given":"Geoffrey R.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D.","family":"Von Hoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Earhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wade J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. D.","family":"Hosley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy A.","family":"Kasunic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00873906_CR1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/978-3-642-65806-8_33","volume-title":"Antineoplastic and Immunosuppressive Agents (II)","author":"BK Bhuyan","year":"1975","unstructured":"Bhuyan BK, Smith CG: Nogalamycin.In Sartorelli AC, and Johns DG (eds) Antineoplastic and Immunosuppressive Agents (II). Springer Verlag, New York, 1975, pp 623\u2013632"},{"key":"BF00873906_CR2","first-page":"1971","volume":"63","author":"GL Neil","year":"1979","unstructured":"Neil GL, Kuentzel SL, McGovren JP: Treatment of mouse tumors with 7-con-0-methylnogarol and other analogs of the anthracycline antibiotic, nogalamycin. Cancer Treat Rep 63:1971\u20131978, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF00873906_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(81)90025-9","volume":"36","author":"WC Krueger","year":"1981","unstructured":"Krueger WC, Pschigoda LM, Schpok SLF, Moscowitz A, McGovren JP, Neta P, Merritt MV, Li LH: The interaction of nogalamycin and analogs with DNA and other biopolymers. Chem-Biol Interactions 36:1\u201318, 1981","journal-title":"Chem-Biol Interactions"},{"key":"BF00873906_CR4","first-page":"30","volume":"19","author":"LH Li","year":"1978","unstructured":"Li LH, Murch LL, Wooden JM, Krueger WC, Pschigoda LM: Inhibition of DNA and RNA polymerases by nogalamycin and its analogs. Proc Am Assoc Cancer Res 19:30, 1978","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00873906_CR5","unstructured":"Clinical Brochure for Intravenous and Orally Administered Tomosar SP in the Treatment of Cancer. The Upjohn Company, December 1986"},{"key":"BF00873906_CR6","first-page":"4849","volume":"39","author":"JP McGovren","year":"1979","unstructured":"McGovren JP, Neil GL, Denlinger RH, Hall TL, Crampton SL, Swenberg JA: Chronic cardiotoxicity studies in rabbits with 7-con-0-methylnogarol, a new anthracycline antitumor agent. Cancer Res 39:4849\u20134855, 1979","journal-title":"Cancer Res"},{"key":"BF00873906_CR7","first-page":"2562","volume":"46","author":"FA Dorr","year":"1986","unstructured":"Dorr FA, Von Hoff DD, Kuhn JG, Schwartz R, Kisner DL: Phase I clinical investigation of 7-con-0-methylnogaril, a new anthracycline antibiotic. Cancer Res 46:2562\u20132565, 1986","journal-title":"Cancer Res"},{"key":"BF00873906_CR8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/JCO.1986.4.5.767","volume":"4","author":"P Dodion","year":"1986","unstructured":"Dodion P, Sessa C, Joss N, Crespeigne N, Willems Y, Kitt M, Abrams J, Finet C, Brewer JE, Adams WJ, Earhart RH, Rozencweig M, Kenis Y, Cavalli F: Phase I study of intravenous menogaril administered intermittently. J Clin Oncol 4:767\u2013774, 1986","journal-title":"J Clin Oncol"},{"key":"BF00873906_CR9","first-page":"721","volume":"70","author":"LM Sigman","year":"1986","unstructured":"Sigman LM, Van Echo DA, Egorin MJ, Whitacre MY, Aisner J: Phase I trial of menogaril as an intermittant daily infusion for five days. Cancer Treat Rep 70:721\u2013725, 1986","journal-title":"Cancer Treat Rep"},{"key":"BF00873906_CR10","first-page":"167","volume":"26","author":"AS Zimet","year":"1985","unstructured":"Zimet AS, Ohnuma T, Perlow L, Coffey VA, Holland JF, Goldsmith MA: A phase I trial of menogaril (7-con-0- methylnogaril) in a daily \u00d7 3 schedule. Proc Am Assoc Cancer Res 26:167, 1985","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00873906_CR11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.1987.5.1.92","volume":"5","author":"TD Brown","year":"1987","unstructured":"Brown TD, Donehower RC, Grochow LB, Rice AP, Ettinger DS: A phase I study of menogaril in patients with advanced cancer. J Clin Oncol 5:92\u201399, 1987","journal-title":"J Clin Oncol"},{"key":"BF00873906_CR12","first-page":"189","volume":"28","author":"DJ Stewart","year":"1987","unstructured":"Stewart DJ, Maroun J, Verma S: Phase I study of onceweekly IV menogaril. Proc Am Assoc Cancer Res 28:189, 1987","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00873906_CR13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00171586","volume":"2","author":"JP McGovren","year":"1984","unstructured":"McGovren JP, Nelson KD, Lassus M, Cradock JD, Plowman J, Christopher JP: Menogaril: A new anthracycline agent entering clinical trials. Invest New Drugs 2:359\u2013367, 1984","journal-title":"Invest New Drugs"},{"key":"BF00873906_CR14","first-page":"212","volume-title":"Pharmacokinetics","year":"1982","unstructured":"Gibaldi M, Perrier D (eds): Pharmacokinetics. Marcel Dekker, New York, 1982, p 212"},{"key":"BF00873906_CR15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01060890","volume":"9","author":"KS Pang","year":"1981","unstructured":"Pang KS: Metabolite pharmacokinetics: The area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites. J Pharmacokin Biopharm 9:477\u2013487, 1981","journal-title":"J Pharmacokin Biopharm"},{"key":"BF00873906_CR16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/02841868809093580","volume":"27","author":"P Dodion","year":"1988","unstructured":"Dodion P, DeValeriola D, Crespeigne N, Peeters B, Wery F, van Berchem C, Joggi J, Kennis Y: Phase I clinical trial of oral menogaril administered on three consecutive days. Acta Oncolog 27:517\u2013520, 1988","journal-title":"Acta Oncolog"},{"key":"BF00873906_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00216923","volume":"8","author":"DJ Stewart","year":"1990","unstructured":"Stewart DJ, Verma S, Maroun JA, Robillard L, Earhart RH: Phase I study of oral menogaril administered on a once weekly schedule. Invest New Drugs 8:43\u201352, 1990","journal-title":"Invest New Drugs"},{"key":"BF00873906_CR18","first-page":"6104","volume":"47","author":"EA Egorin","year":"1987","unstructured":"Egorin EA, Conley BA, Forrest A, Zuhowski EG, Sinibaldi V, Van Echo DA: Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction. Cancer Res 47:6104\u20136110, 1987","journal-title":"Cancer Res"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873906.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00873906\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873906.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T03:08:22Z","timestamp":1682910502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00873906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,2]]}},"alternative-id":["BF00873906"],"URL":"https:\/\/doi.org\/10.1007\/bf00873906","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,2]]}}}